1159010-21-5

Basic information

• Product Name: 4-(2-oxo-2,3-dihydro-imidazo[4,5-b]pyridin-1-yl)-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-4'-carboxylic acid
• Synonyms: 4-(2-oxo-2,3-dihydro-imidazo[4,5-b]pyridin-1-yl)-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-4'-carboxylic acid
• CAS NO: 1159010-21-5
• Molecular Weight: 339.354
• Mol File: 1159010-21-5.mol

Chemical Properties

• CAS DataBase Reference: 4-(2-oxo-2,3-dihydro-imidazo[4,5-b]pyridin-1-yl)-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-4'-carboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(2-oxo-2,3-dihydro-imidazo[4,5-b]pyridin-1-yl)-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-4'-carboxylic acid(1159010-21-5)
• EPA Substance Registry System: 4-(2-oxo-2,3-dihydro-imidazo[4,5-b]pyridin-1-yl)-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-4'-carboxylic acid(1159010-21-5)

Safety Data

• Hazardous Substances Data: 1159010-21-5(Hazardous Substances Data)

Upstream product

• 185961-99-3 1-(piperidin-4-yl)-1,3-dihydro-2H-imidazo[4,5-b]pyridin-2-one 
• 66572-56-3 2-bromoisonicotinic acid 
• 19099-93-5 benzyl 4-oxo-1-piperidinecarboxylate 

Relevant articles and documents

NOVEL COMPOUNDS

The present invention relates to new CGRP-antagonists of general formula I wherein U, V, X, Y, R1, R2, R3 and R4 are defined as mentioned in the description, the tautomers thereof, the isomers thereof, the diastereomers thereof, the enantiomers thereof, the hydrates thereof, the mixtures thereof and the salts thereof as well as the hydrates of the salts, particularly the physiologically acceptable salts thereof with inorganic or organic acids or bases, medicaments containing these compounds, the use thereof and processes for the preparation thereof.